Climb Global Solutions, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Climb Global Solutions, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $652.52M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $465.61M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $352.01M | Feb 27, 2026 |
| FY2017 | Dec 31, 2017 | $126.96M | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | $106.65M | Mar 15, 2018 |
| FY2017 | Jun 30, 2017 | $102.98M | Mar 15, 2018 |
| FY2017 | Mar 31, 2017 | $112.80M | Mar 15, 2018 |
| FY2017 | Dec 31, 2016 | $119.97M | Mar 15, 2018 |
| FY2017 | Sep 30, 2016 | $99.59M | Mar 15, 2018 |
| FY2017 | Jun 30, 2016 | $105.26M | Mar 15, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $352.01M | Mar 5, 2024 |
| FY2023 | Dec 31, 2022 | $304.35M | Mar 5, 2024 |
| FY2021 | Dec 31, 2021 | $75.51M | Mar 9, 2022 |
| FY2021 | Sep 30, 2021 | $68.91M | Mar 9, 2022 |
| FY2021 | Jun 30, 2021 | $75.35M | Mar 9, 2022 |
| FY2021 | Mar 31, 2021 | $62.81M | Mar 9, 2022 |
| FY2021 | Dec 31, 2020 | $71.45M | Mar 9, 2022 |
| FY2021 | Sep 30, 2020 | $60.92M | Mar 9, 2022 |
| FY2021 | Jun 30, 2020 | $56.59M | Mar 9, 2022 |
| FY2021 | Mar 31, 2020 | $62.62M | Mar 9, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.27M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $91.08M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $64.25M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $54.09M | Mar 5, 2024 |
| FY2021 | Dec 31, 2021 | $12.58M | Mar 9, 2022 |
| FY2021 | Sep 30, 2021 | $11.32M | Mar 9, 2022 |
| FY2021 | Jun 30, 2021 | $10.98M | Mar 9, 2022 |
| FY2021 | Mar 31, 2021 | $10.84M | Mar 9, 2022 |
| FY2021 | Dec 31, 2020 | $10.53M | Mar 9, 2022 |
| FY2021 | Sep 30, 2020 | $7.24M | Mar 9, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.33M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $18.61M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $12.32M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $12.50M | Mar 5, 2024 |
| FY2021 | Dec 31, 2021 | $3.45M | Mar 9, 2022 |
| FY2021 | Sep 30, 2021 | $2.44M | Mar 9, 2022 |
| FY2021 | Jun 30, 2021 | $1.79M | Mar 9, 2022 |
| FY2021 | Mar 31, 2021 | $1.52M | Mar 9, 2022 |
| FY2021 | Dec 31, 2020 | $2.53M | Mar 9, 2022 |
| FY2021 | Sep 30, 2020 | $530.0K | Mar 9, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.19M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $27.99M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $16.49M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $17.31M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $12.05M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $5.30M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $8.47M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $4.16M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $7.81M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $8.62M | Mar 18, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.55M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $56.51M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $44.33M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $34.14M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $32.14M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $23.93M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $20.89M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $20.32M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $19.26M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $18.72M | Mar 18, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.60M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $33.74M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $42.12M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $4.56M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $4.71M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $37.97M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $3.25M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $13.90M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | ($2.02M) | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | ($516.0K) | Mar 18, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $460.23M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $469.18M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $335.10M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $231.86M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $190.75M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $165.53M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $126.28M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $107.97M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $104.69M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $116.25M | Mar 18, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $343.65M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $378.59M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $260.33M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $171.28M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $138.34M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $120.82M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $81.03M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $67.40M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $65.98M | Mar 18, 2019 |
| FY2012 | Dec 31, 2012 | $59.32M | Feb 15, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $116.58M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $90.59M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $74.77M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $60.57M | Feb 27, 2026 |
| FY2023 | Dec 31, 2021 | $52.42M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $44.72M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $45.26M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $40.57M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $38.71M | Mar 4, 2020 |
| FY2018 | Dec 31, 2016 | $37.61M | Mar 18, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.84M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $34.92M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $27.18M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $18.96M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $17.19M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $16.82M | Mar 16, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.04M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $68.79M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $53.22M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $43.90M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $34.40M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $28.19M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $26.72M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $22.99M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $22.52M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $20.52M | Mar 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.56M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $29.78M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $36.30M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $20.25M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $29.27M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $29.35M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $14.98M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $14.88M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $5.53M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $13.52M | Mar 15, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.30M | Mar 5, 2024 |
| FY2023 | Dec 31, 2022 | $1.80M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Mar 16, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | 2 | Mar 5, 2024 |
| FY2021 | Dec 31, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 9, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Mar 9, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | 2 | Mar 5, 2024 |
| FY2021 | Dec 31, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 9, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 9, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Mar 9, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.61M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 4.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 4.57M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 4.48M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | 4.42M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 4.36M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | 4.51M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | 4.50M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | 4.45M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | 4.56M | Mar 15, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $3.01M | Mar 5, 2024 |
| FY2023 | Dec 31, 2022 | $2.99M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $2.99M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $3.00M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $3.07M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $3.07M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $3.06M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $3.20M | Mar 18, 2019 |
| FY2017 | Dec 31, 2015 | $3.24M | Mar 15, 2018 |
| FY2016 | Dec 31, 2014 | $3.23M | Feb 21, 2017 |